A harlequin is a comic character from Italian theater, traditionally dressed in a diamond-patterned costume and known for acrobatic antics. The word has been in use since the 16th century, originating from the “commedia dell’arte” tradition, where the Harlequin (Arlecchino) played a mischievous servant. Today, the term appears in several contexts: it describes a color pattern in animals like Great Danes and rabbits, a well-known romance novel publisher (Harlequin Books), and two distinct medical conditions. Because the medical meanings are the ones that generate the most urgent questions, they’re worth understanding in detail.
The Theatrical Character
The original Harlequin was a stock character in commedia dell’arte, a form of improvisational theater that flourished in Italy from the 1500s onward. He wore a tight-fitting costume covered in colorful diamond shapes and carried a wooden sword or slapstick. His role was the clever, agile servant who outwitted his master and other characters through physical comedy and quick thinking. Over centuries, the character migrated into French pantomime and British theater, where the diamond costume became iconic enough to lend its name to patterns, colors, and eventually medical conditions that feature dramatic visual contrasts on the body.
Harlequin Ichthyosis: A Severe Skin Condition
In medicine, harlequin ichthyosis is an extremely rare genetic skin disorder that affects roughly 1 in 300,000 births. It is the most severe form of ichthyosis, a family of conditions involving abnormal skin scaling. Babies born with harlequin ichthyosis have thick, dry, armor-like plates of skin separated by deep cracks (fissures) covering nearly their entire body. The condition is present at birth and visible immediately.
The thick skin plates pull tightly on surrounding tissue, which causes the eyelids to turn outward (a feature called ectropion) and the lips to pull back from the mouth (eclabium). The nostrils and ears may also be underdeveloped or flattened. Movement of the arms and legs is restricted because the rigid skin acts like a cast around the joints. These features give affected newborns a striking, unmistakable appearance that historically led to the “harlequin” name, a reference to the patterned look of the skin plates.
What Causes It
Harlequin ichthyosis is caused by mutations in a gene called ABCA12. This gene provides instructions for a protein that transports fats (lipids) to the outermost layer of skin. In healthy skin, tiny structures inside skin cells package these lipids and release them into the spaces between cells, forming a waterproof barrier. When ABCA12 doesn’t work properly, lipids accumulate inside the cells instead of reaching the surface. The result is massive overgrowth of the outermost skin layer.
The condition follows an autosomal recessive inheritance pattern, meaning a child must inherit a defective copy of the gene from both parents. Parents who each carry one mutated copy typically have completely normal skin and no symptoms. Research has identified multiple types of ABCA12 mutations in affected families, including large deletions of genetic material and smaller frameshift errors that produce a severely shortened, nonfunctional protein. In a study of 12 patients, 11 carried identifiable mutations in ABCA12.
Life-Threatening Complications in Newborns
The cracked, rigid skin creates several immediate dangers. Deep fissures allow bacteria to enter the body, and infection, including sepsis, is one of the leading causes of death in affected newborns. The tight skin around the chest restricts breathing, and respiratory failure is another major risk. Babies also lose water and heat rapidly through damaged skin, leading to dehydration and dangerous shifts in electrolyte levels. Difficulty feeding, low blood sugar, and kidney stress add further complications. Without specialized care, most affected newborns historically died within days of birth.
Modern neonatal intensive care has significantly improved outcomes. Treatment focuses on maintaining humidity around the baby (typically in a specialized incubator), preventing infections through careful hygiene and antibiotics when needed, monitoring kidney function and electrolyte balance, and softening and hydrating the skin one to two times daily to encourage the thick outer layer to shed. Eye care is critical because the turned-out eyelids leave the eyes exposed to drying and infection. Lubricating ointments are applied regularly, and in some cases surgery is needed to correct the eyelid positioning.
Long-Term Management for Survivors
Babies who survive the newborn period eventually shed the thick plates, but their skin remains abnormally dry, red, and scaly throughout life. Long-term management centers on medications derived from vitamin A, known as retinoids. These drugs help regulate how skin cells grow and shed, reducing the buildup of thick, scaly skin. Most patients with harlequin ichthyosis are treated with oral retinoids, and improvement in skin flexibility, eyelid closure, lip position, and limb movement has been observed within a week of starting treatment.
Treatment duration varies widely. Some patients require retinoid therapy for years, and some need it indefinitely to prevent the skin from thickening again. Doctors aim to use the lowest effective dose to minimize side effects over the long term. For women of childbearing age, the choice of specific retinoid matters because these drugs carry a risk of birth defects, and some formulations clear the body faster than others.
Prenatal Detection
Because harlequin ichthyosis is genetic, families with a known history can pursue prenatal testing. Detailed ultrasound, particularly 3D and 4D imaging performed around 26 weeks of pregnancy, can reveal characteristic features: eversion of the eyelids and lips, clenched fists, incurved toes, short foot length, and excess amniotic fluid. Genetic testing of fetal DNA can confirm ABCA12 mutations directly. For families who have already had an affected child, these options allow earlier diagnosis and preparation in subsequent pregnancies.
Harlequin Syndrome: A Different Condition
Harlequin syndrome is an entirely separate condition that shares only the name. First described in 1988, it involves a dramatic split in facial color: one half of the face flushes red and sweats normally, while the other half stays pale and dry. The dividing line runs straight down the middle of the face. It is triggered by exercise, heat, emotional stress, or spicy food.
The cause is a disruption in the sympathetic nerve fibers that control blood vessel widening and sweating on one side of the face. In more than half of cases, no underlying cause is found. In others, it results from injury, compression, or surgical procedures affecting nerve pathways in the neck or upper chest. Unlike harlequin ichthyosis, harlequin syndrome has no genetic basis, causes no sensory or movement problems, and is not dangerous. It is primarily a cosmetic concern, though its sudden appearance can understandably alarm someone who doesn’t know what it is.

